Fluidigm is the creator and world’s leading supplier of integrated fluidic circuits. Fluidigm microfluidic chips, systems, assays and other reagents enable genetic analysis that in many instances were previously impractical. To help its customers achieve and exploit advances in life science research, agricultural biotechnology, or Ag-Bio, and molecular diagnostics, Fluidigm provides robust systems that deliver high throughput and simpler workflows at decreased costs. Fluidigm microfluidic systems overcome many of the limitations of conventional laboratory systems by integrating a vast number of fluidic components onto a single microfabricated chip. Fluidigm technology enables its customers to perform and measure thousands of sophisticated biochemical reactions on samples smaller than the content of a single cell, while utilizing minute volumes of reagents and samples. Similarly, for next generation DNA sequencing, Fluidigm systems enable rapid preparation of multiple samples in parallel at low cost.Use of Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding our plans, objectives, expectations and strategies for our China subsidiary, business and related future growth. Forward-looking statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from currently anticipated results. Factors that could materially affect future results include, but are not limited to, our ability to expand our customer base, introduce new applications and successfully compete in our markets and industry, risks relating to international operations, global economic conditions, and the other risk factors contained in our filings with the Securities and Exchange Commission, including our most recent filings on Forms 10-K and 10-Q. These forward-looking statements speak only as of the date hereof. Fluidigm Corporation disclaims any obligation to update these forward-looking statements. About Fluidigm Fluidigm (NASDAQ:FLDM) develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or Ag-Bio, industries. Fluidigm’s proprietary microfluidic systems consist of instruments and consumables, including chips, assays and other reagents. These systems are designed to significantly simplify experimental workflow, increase throughput and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm actively markets three microfluidic systems, including eight different commercial chips, to leading pharmaceutical and biotechnology companies, academic institutions and Ag-Bio companies.
For more information, please visit www.fluidigm.com.Fluidigm and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation. Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50237474&lang=en